A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older

PHASE3CompletedINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

October 10, 2016

Primary Completion Date

December 2, 2016

Study Completion Date

May 8, 2017

Conditions
Influenza, Human
Interventions
BIOLOGICAL

GC3110A vaccine

0.5mL, Intramuscular

Trial Locations (10)

Unknown

The Catholic Univ. of Korea Daejeon St.Mary's Hospital, Daejeon

Soon Chun Hyang University Bucheon Hospital, Gyeonggi-do

The Catholic Univ.of Korea Bucheon St.Mary's Hospital, Gyeonggi-do

The Catholic Univ.of Korea Uijeongbu St.Mary's Hospital, Gyeonggi-do

EWHA woman's university mokdong hospital, Seoul

KyungHee University Medical Center, Seoul

Soon Chun Hyang University Seoul Hospital, Seoul

The Catholic Univ. of Korea Incheon St.Mary's Hospital, Seoul

The Catholic Univ.of Korea Seoul St.Mary's Hospital, Seoul

The Catholic Univ.of Korea Yeouido St.Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY